Delayed alternation performance following subchronic phencyclidine administration in rats depends on task parameters.
Jean-Philippe Marquis, Marie-Claude Audet, François Y Doré, Sonia Goulet
Progress in Neuro-Psychopharmacology and Biological Psychiatry June 30, 2007 DOI: 10.1016/j.pnpbp.2007.03.017 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study Peer reviewed |
|---|---|
| Sample size | 32 |
| Population | Rats |
| Dose | 10 mg/kg |
| Duration | 14-day treatment, testing for 10 days starting 48 h after last injection |
| Key findings | PCP-treated rats were impaired relative to controls in the continuous alternation task, whereas performance did not differ between PCP and saline groups in the discrete trials version. The authors propose that task parameter differences may explain inconsistent findings on PCP's cognitive effects. |
Abstract
The cognitive effects of subchronic phencyclidine administration in rats are still unsettled in the literature. Possible causes of discrepancies are different drug treatment regimens and task parameters. The current experiment tested whether variations in procedures of the delayed T-maze alternation task result in performance differences following identical PCP treatments. Sixteen rats were trained on a continuous version of the T-maze task where they alternated between successive free-choice runs. Another sixteen were trained on a discrete trials version where each trial started with a forced run followed by a free choice test. After training, half of the rats submitted to each task version were treated daily for 14 days with i.p. injections of PCP (10 mg/kg) and the remaining half received a saline solution. At 48 h after the last injection, the subjects were tested for 10 days in their respective task version. Results showed that rats treated with PCP were impaired relative to controls in the continuous alternation task whereas performance of PCP and Saline groups did not differ in the discrete trials version. Cognitive control from prefrontal cortex and/or striatal response-related processes could have been damaged by PCP exposure. The systematic study of differences in tasks parameters may help reconcile discordant findings on PCP's functional outcomes.
Citations in the library
Cited by 3
- Abnormal neural activation patterns underlying working memory impairment in chronic phencyclidine-treated mice. PLoS One 2017
- The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia. Psychopharmacology November 2015
- Enhanced anxiety follows withdrawal from subchronic exposure to phencyclidine in rats. Behavioural Brain Research January 25, 2007
Cites 5
- Transient hypolocomotion in rats repeatedly exposed to phencyclidine: an appraisal of motor function and motivation. Progress in neuro-psychopharmacology & biological psychiatry January 30, 2007
- Enhanced anxiety follows withdrawal from subchronic exposure to phencyclidine in rats. Behavioural Brain Research January 25, 2007
- The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm. Behavioural Brain Research May 15, 2006
- Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Psychopharmacology December 2005
- The role of striatal dopaminergic mechanisms in rotational behavior induced by phencyclidine and phencyclidine-like drugs. Psychopharmacology 1998